Evidence map›Paper›PMID 31978062›Full record

ArticlePloS one2020

Selective transmission of some HIV-1 subtype C variants might depend on Envelope stimulating dendritic cells to secrete IL-10.

Evelyn Ngwa Lumngwena, Bianca Abrahams, Liliwe Shuping, Claudia Cicala, James Arthos, Zenda Woodman

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Evelyn Ngwa LumngwenaDepartment of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Bianca AbrahamsDepartment of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Liliwe ShupingNational Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
Claudia CicalaNational Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, Maryland, United States of America.
James ArthosNational Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, Maryland, United States of America.
Zenda WoodmanDepartment of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.ORCID 0000-0001-9680-3884
University of Cape Town · ZANational Institute of Allergy and Infectious Diseases · USNational Health Laboratory Service · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Envelope (Env) phenotype(s) that provide transmitted founders (TF) with a selective advantage during HIV-1 transmission would be the ideal target for preventative therapy. We generated Env clones from four individuals infected with a single virus and one participant infected with multiple variants at transmission and compared phenotype with matched Envs from chronic infection (CI). When we determined whether pseudovirus (PSV) of the five TF and thirteen matched CI Env clones differed in their ability to 1) enter TZM-bl cells, 2) bind DC-SIGN, and 3) trans-infect CD4+ cells there was no association between time post-infection and variation in Env phenotype. However, when we compared the ability of PSV to induce monocyte-derived dendritic cells (MDDCs) to secrete Interleukin-10 (IL-10), we found that only TF Envs from single variant transmission cases induced MDDCs to secrete either higher or similar levels of IL-10 as the CI clones. Furthermore, interaction between MDDC DC-SIGN and Env was required for secretion of IL-10. When variants were grouped according to time post-infection, TF PSV induced the release of higher levels of IL-10 than their CI counterparts although this relationship varied across MDDC donors. The selection of variants during transmission is therefore likely a complex event dependent on both virus and host genetics. Our findings suggest that, potentially due to overall variation in N-glycosylation across variants, nuanced differences in binding of TF Env to DC-SIGN might trigger alternative DC immune responses (IRs) in the female genital tract (FGT) that favour HIV-1 survival and facilitate transmission.

Indexed as

Genetic VariationCell Adhesion MoleculesDC-Specific ICAM-3 Grabbing NonintegrinDendritic Cellsenv Gene Products, Human Immunodeficiency VirusFemaleGlycosylationHEK293 CellsHIV-1HumansInterleukin-10Lectins, C-TypePhenotypeReceptors, Cell SurfaceVaccines, DNAVirus InternalizationCell Adhesion MoleculesDC-Specific ICAM-3 Grabbing Nonintegrinenv Gene Products, Human Immunodeficiency VirusInterleukin-10Lectins, C-TypeReceptors, Cell SurfaceVaccines, DNA

Identifiers

PMID31978062
PMCPMC6980567
OpenAlexW3001283749

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.